Myelofibrosis complicated by infection due to Candida albicans: emergence of resistance to antifungal agents during therapy

Clin Infect Dis. 1997 Dec;25(6):1470-1. doi: 10.1086/516987.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Candidiasis / complications*
  • Candidiasis / drug therapy*
  • Drug Resistance, Microbial
  • Humans
  • Male
  • Middle Aged
  • Primary Myelofibrosis / complications*
  • Primary Myelofibrosis / drug therapy

Substances

  • Antifungal Agents
  • Amphotericin B